LabCorp Service Announcement LabCorp Launches Interleukin 28B Polymorphism (IL28B) Genotype Test to Support Individualized Treatment Decisions for Patients with Hepatitis C Viral Infection. As a specialty provider of HCV - Monogram Biosciences - Document - PDFSEARCH.IO

First Page	Meta Content
	LabCorp Service Announcement LabCorp Launches Interleukin 28B Polymorphism (IL28B) Genotype Test to Support Individualized Treatment Decisions for Patients with Hepatitis C Viral Infection. As a specialty provider of HCV Add to Reading List Document Date: 2011-11-21 14:16:19 Open Document File Size: 76,15 KB Share Result on Facebook Company European Americans / Ge / Hispanics / LabCorp Service Announcement LabCorp / African Americans / / Continent America / / Event FDA Phase / / Facility Laboratory Corporation / / IndustryTerm hepatitis C treatment / / MedicalCondition Viral Infection / MS / hepatitis C / fibrosis / HCV / HCV genotype / / / Position account representative / / Product ribavirin / IL28B / / ProvinceOrState Connecticut / / Technology Genotype / / SocialTag Hepatitis C virus Cytokines Interleukin 28 Hepatitis C Genome-wide association study Interferon Monogram Biosciences Peginterferon alfa-2a Hepatitis C and HIV co-infection Biology

LabCorp Service Announcement LabCorp Launches Interleukin 28B Polymorphism (IL28B) Genotype Test to Support Individualized Treatment Decisions for Patients with Hepatitis C Viral Infection. As a specialty provider of HCVAdd to Reading List